Human Envelop VLP Control, Accession:

/在： /通过：
  • 产品概述
  • 产品规格
  • 运输及存储
  • 品牌声明

    • 产品概述

    产品描述

    Recombinant Human Envelop VLP Control is expressed from HEK293. Human Envelop VLP Control is formed by self-assembly of envelop/capsid proteins from viruses, which is pure viral protein particle structure without the displayed proteins. Human Envelop VLP Control can be used as isoytype control for VLPs displaying membrane proteins in various applications.

    Biotinylated

    产品规格

    靶点

    Envelop VLP Control

    分子别名

    Gag polyprotein; Pr55Gag; MA; CA; SP1; p2; nc; SP2; p1; p6-gag

    Accession

    种属

    Human

    蛋白序列

    分子量

    活性

    产品标签

    表达系统

    HEK293

    纯度

    > 95% as determined by HPLC

    内毒素

    Less than 1EU per ug by the LAL method.

    运输及存储

    产品外观

    Lyophilized

    运输条件

    Shipped at ambient temperature.

    制剂

    Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.

    复溶

    Centrifuge tubes before opening. Reconstituting to a concentration more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water.

    存储和稳定性

    Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

    该产品的品牌ChemWhat是Watson的注册商标，由Watson授权江苏沃尔森在中国大陆地区使用，ChemWhat官方网址.